AAGHOTCPharmaceutical PreparationsFiscal year ends June 30
America Great Health
Financials through Q3 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Aug 6, 2026
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $12.69M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$0.0005 (+500.0%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
America Great Health saw revenue fall 5.1% to $363.33K over the twelve months to Mar 31, 2026.
Revenue
$363.33K
-5.1% vs. a year earlier
Operating income
-$382.18K
TTM Q3 2026
EPS, diluted
$0.00
TTM Q3 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Mar 31, 2026
Valuation
- Market cap
- $12.69M
- P/E ratio
- –
- Price to sales
- 34.93
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $363.33K
- Net income
- $639.11K
- EPS, diluted
- $0.00
- Book value per share
- -$0.00
- Diluted shares
- 21.15B
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$363.33K-5.1% YoY
Gross profit
$249.16K-1.5% YoY
Operating income
-$382.18K
Net income
$639.11K
EPS, diluted
$0.00
Free cash flow
–
Reported periodTrailing twelve months